Alkermes, Inc. (NASDAQ:ALKS)

CAPS Rating: 3 out of 5

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

Recs

1
Player Avatar PickThatBooger (28.70) Submitted: 11/15/2010 6:23:09 PM : Underperform Start Price: $15.85 ALKS Score: +28.51

Almost got the top on this one.

Featured Broker Partners


Advertisement